-
Journal of Experimental Pharmacology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Effects of single-dose morning and evening administration of pravastatin on antioxidant markers in cholesterol-fed rabbits
Original Research
(1964) Views (373) Full article downloads
Authors: Kamal S
Published Date May 2011
Volume 2011:3 Pages 51 - 58
DOI: http://dx.doi.org/10.2147/JEP.S19449
Sahar Mohamed KamalDepartment of Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Background: Accurate timing of statin administration is considered important to obtain the best hypolipidemic effect. Pravastatin is one of the currently prescribed hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, and was chosen in this study to evaluate its antioxidant effect when administered as a single daily dose in the morning versus evening in cholesterol-fed rabbits.
Methods: This 12-week study was performed in New Zealand rabbits, divided into four groups (n = 6 each), ie, normocholesterolemic controls; cholesterol 1% diet, nontreated ; cholesterol 1% diet treated with pravastatin in the morning; and cholesterol 1% diet treated with pravastatin in the evening. Plasma total cholesterol levels, superoxide dismutase enzyme levels in erythrocyte lysates, thiobarbituric acid-reactive substance content, catalase, and glutathione enzyme activity in liver homogenates from the tested rabbits were measured.
Results: Both morning and evening treatment with pravastatin significantly improved all the measured antioxidant markers in comparison with nontreated cholesterol-fed rabbits. However, results obtained with evening dosing were better than with morning dosing.
Conclusion: The antioxidant profile of pravastatin is better when the drug is administered in the evening rather than in the morning.
Keywords: pravastatin, chronotherapy, antioxidant markers, cholesterol-fed rabbits
Other articles by Dr Sahar Kamal
Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
Pharmacological modulation of brain levels of glutamate and GABA in rats exposed to total sleep deprivation
Readers of this article also read:
Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
Potential antidiabetic and antioxidant activities of Morus indica and Asystasia gangetica in alloxan-induced diabetes mellitus
Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male wistar albino rats
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
The influence of dexamethasone and the role of some antioxidant vitamins in the pathogenesis of experimental bronchial asthma
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
Drug-resistant tuberculosis: emerging treatment options
Restoration of renal hemodynamics and functions during black cumin (Nigella sativa) administration in streptozotocin-induced diabetic rats
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




